Different apoptotic responses of RA synoviocytes depending on different genotypes of the mdm2 SNP T309G

Area of Science:

• Molecular Biology
• Immunology
• Genetics

Background:

• Mdm2 is an E3 ubiquitin ligase that inhibits p53-mediated apoptosis.
• The mdm2 SNP309 polymorphism (T309G) has been associated with a protective effect in rheumatoid arthritis (RA).
• The functional impact of mdm2 SNP309 genotypes on apoptosis in RA synoviocytes remains unexplored.

Purpose of the Study:

• To investigate the functional impact of mdm2 SNP309 genotypes on apoptosis in rheumatoid arthritis (RA) synoviocytes.
• To determine if the mdm2 SNP309 polymorphism influences apoptosis rates in RA.
• To explore the potential protective mechanism of the mdm2 SNP309 minor allele in RA.

Main Methods:

• Genomic DNA was isolated from 49 RA patient-derived synoviocyte cell lines.
• m mdm2 SNP309 genotypes were determined using polymerase chain reaction and restriction enzyme analysis.
• Apoptosis rates were measured by propidium iodide staining and flow cytometry (FACS) in cell lines with TT and GG genotypes, with and without TNF-alpha and Il-1beta stimulation.

Main Results:

• Cell lines with the mdm2 SNP309 GG genotype (minor allele) exhibited significantly higher apoptosis rates compared to those with the TT genotype (major allele).
• This difference was observed both in the presence (19.4 ± 3.6% vs. 26.9 ± 1.8%; P = 0.02) and absence (27.4 ± 8.8% vs. 43.9 ± 2.4%; P = 0.0002) of TNF-alpha and Il-1beta stimulation.
• In vitro RA synoviocyte cultures showed increased apoptotic activity in GG homozygous individuals.

Conclusions:

• The mdm2 SNP309 GG genotype is associated with enhanced apoptotic activity in RA synoviocytes.
• This finding supports a potential protective role for the mdm2 SNP309 minor allele in rheumatoid arthritis.
• The differential apoptosis rates linked to mdm2 SNP309 genotypes may contribute to the observed protective effect in RA.